|
|
CRO BioDuro Signs Collaboration with AstraZeneca in Beijing
publication date: Mar 17, 2009
BioDuro and AstraZeneca held a signing ceremony in Beijing today to formalize their new collaboration. BioDuro is a CRO based in the US, though its operations are entirely in Beijing. The company offers end-to-end medicinal chemistry services, either from its team of 580 or through affiliations with partners. AstraZeneca produced revenues of more than $31 billion last year from its portfolio of pharmaceuticals. More details... Stock Symbol: (NYSE: AZN)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|